Literature DB >> 16694656

AUTOLOGOUS AND HOMOLOGOUS TRANSFUSION OF HUMAN ASCITIC FLUID.

H A Davis1, J F Blalock.   

Abstract

Entities:  

Year:  1939        PMID： 16694656      PMCID： PMC434869          DOI： 10.1172/JCI101037

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  THE EFFECT OF SERUM TRANSFUSION ON THE PLASMA PROTEIN DEPLETION ASSOCIATED WITH NUTRITIONAL EDEMA IN DOGS.

Authors:  A A Weech; E Goettsch; E B Reeves
Journal:  J Clin Invest       Date:  1933-01       Impact factor: 14.808

2.  The excretion of protein by the mammalian kidney.

Authors:  L E Bayliss; P M Kerridge; D S Russell
Journal:  J Physiol       Date:  1933-03-15       Impact factor: 5.182

3.  TREATMENT OF HEMORRHAGE AND TRAUMATIC SHOCK BY THE INTRAVENOUS USE OF LYOPHILE SERUM.

Authors:  D D Bond; D G Wright
Journal:  Ann Surg       Date:  1938-04       Impact factor: 12.969

4.  A STUDY OF EXPERIMENTAL AND CLINICAL SHOCK WITH SPECIAL REFERENCE TO ITS TREATMENT BY THE INTRAVENOUS INJECTION OF PRESERVED PLASMA.

Authors:  E B Mahoney
Journal:  Ann Surg       Date:  1938-08       Impact factor: 12.969

5.  MAMMALIAN LIFE WITHOUT RED BLOOD CORPUSCLES.

Authors:  W R Amberson; A G Mulder; F R Steggerda; J Flexner; D S Pankratz
Journal:  Science       Date:  1933-08-04       Impact factor: 47.728
  5 in total
  4 in total

1.  Surgical treatment of portal hypertension: a historical perspective.

Authors:  A J Donovan
Journal:  World J Surg       Date:  1984-10       Impact factor: 3.352

2.  Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study.

Authors:  Ken Ishitani; Ayako Isoai; Tetsuya Ito; Hiroshi Sugiyama; Atsushi Arakawa; Yosuke Yamada; Hirokazu Onodera; Ryosuke Kobayashi; Naoko Torii; Noriko Soneda; Yoshihiro Matsuno; Taiju Utsugisawa; Michio Kato; Norio Hanafusa
Journal:  Int J Clin Oncol       Date:  2021-03-24       Impact factor: 3.402

3.  Peritoneovenous shunting for intractable cirrhotic and cancerous ascites using different types of shunting tubes.

Authors:  K Akimaru; Y Ueda; T Shoji
Journal:  Jpn J Surg       Date:  1988-09

4.  Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results.

Authors:  Norio Hanafusa; Ayako Isoai; Tomoaki Ishihara; Tetsuya Inoue; Ken Ishitani; Taiju Utsugisawa; Toshihiko Yamaka; Tetsuya Ito; Hiroshi Sugiyama; Atsushi Arakawa; Yosuke Yamada; Yasuo Itano; Hirokazu Onodera; Ryosuke Kobayashi; Naoko Torii; Toyoko Numata; Taihei Kashiwabara; Yoshihiro Matsuno; Michio Kato
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.